当前位置:
首页>产品中心>单抗/多抗>Anti-Ranibizumab Polyclonal Antibody|抗雷珠单抗多克隆抗体(靶标:雷珠单抗(抗VEGF单抗))
Anti-Ranibizumab Polyclonal Antibody|抗雷珠单抗多克隆抗体(靶标:雷珠单抗(抗VEGF单抗))
- 货号:RB9TAB941014
- 价格:面议
- 点击:277
产品介绍
产品参数
| 形态 | Liquid |
|---|
| 宿主种属 | Rabbit |
|---|
| 克隆性 | Polyclonal |
|---|
| 抗体亚型 | IgG |
|---|
| 纯化方式 | Purified by antigen affinity column. |
|---|
| 内毒素水平 | Please contact with the lab for this information. |
|---|
| 应用 | ELISA |
|---|
| 特异性 | The product is specific for Ranibizumab. This antibody serves as an excellent positive control for Ranibizumab immunogenicity (ADA) assays. |
|---|
| 靶标 | Rabbit polyclonal to Lucentis. |
|---|
| 免疫原 | Ranibizumab |
|---|
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
|---|
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
|---|
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
|---|
| 登录号 | CAS: 347396-82-1 |
|---|
| 背景信息 | Ranibizumab with trade name Lucentis, is an FDA-approved drug for the treatment of patients with neovascular (Wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO). It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment. Ranibizumab binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity. Antibodysystem Anti-Ranibizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ranibizumab.
|
|---|
| 备注 | For research use only. |
|---|
【仅供科学研究使用】
相关产品: